Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
9.28
-0.91 (-8.93%)
At close: May 14, 2025, 4:00 PM
9.31
+0.03 (0.32%)
After-hours: May 14, 2025, 7:51 PM EDT

Syndax Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
7991,1281,8331,7331,1841,048
Upgrade
Market Cap Growth
-47.74%-38.43%5.75%46.42%12.95%339.76%
Upgrade
Enterprise Value
6287231,4611,384969893
Upgrade
Last Close Price
9.2813.2221.6125.4521.8922.24
Upgrade
PE Ratio
----47.49-
Upgrade
PS Ratio
18.2247.65--8.47690.79
Upgrade
PB Ratio
3.713.923.313.712.904.16
Upgrade
P/TBV Ratio
3.713.923.313.712.904.16
Upgrade
P/FCF Ratio
----40.81-
Upgrade
P/OCF Ratio
----40.63-
Upgrade
EV/Sales Ratio
14.3630.53--6.94588.50
Upgrade
EV/EBITDA Ratio
----36.90-
Upgrade
EV/EBIT Ratio
----36.96-
Upgrade
EV/FCF Ratio
----33.42-
Upgrade
Debt / Equity Ratio
1.611.200.000.000.050.08
Upgrade
Debt / EBITDA Ratio
----0.79-
Upgrade
Debt / FCF Ratio
----0.72-
Upgrade
Asset Turnover
0.070.04--0.370.01
Upgrade
Quick Ratio
5.695.769.9616.8121.6215.79
Upgrade
Current Ratio
5.805.8210.0016.8521.6815.84
Upgrade
Return on Equity (ROE)
-93.70%-75.69%-40.98%-34.10%7.55%-51.56%
Upgrade
Return on Assets (ROA)
-36.29%-31.74%-25.89%-20.03%4.37%-24.52%
Upgrade
Return on Capital (ROIC)
-40.76%-35.69%-28.06%-21.13%4.67%-29.25%
Upgrade
Return on Capital Employed (ROCE)
----6.10%-
Upgrade
Earnings Yield
-41.48%-28.25%-11.42%-8.62%2.11%-6.98%
Upgrade
FCF Yield
-35.88%-24.36%-8.76%-7.71%2.45%-6.80%
Upgrade
Buyback Yield / Dilution
-15.54%-21.67%-15.82%-13.31%-29.81%-35.48%
Upgrade
Updated May 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q